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Collision of Three Histologically Distinct Endometrial Cancers of 
the Uterus
A collision tumor is defined by the presence of two separate masses in one organ, which 
are pathologically distinct. We described a 70-yr-old patient who complained of abnormal 
vaginal bleeding with a collision tumor of the uterine corpus. The patient received total 
hysterectomy, bilateral salphingo-oophorectomy, bilateral pelvic-paraaortic 
lymphadenectomy, omentectomy, and intraperitoneal chemotherapy. The uterine corpus 
revealed three separate masses, which were located at the fundus, anterior and posterior 
wall. Each tumor revealed three pathologically different components, which were 
malignant mixed müllerian tumor, papillary serous carcinoma, and endometrioid 
adenocarcinoma. Among these components, only the papillary serous carcinoma 
component invaded the underlying myometrium and metastasized to the regional lymph 
node. Adjuvant chemotherapy and radiation therapy were performed. The patient is still 
alive and has been healthy for the last 8 yr. We have reviewed previously reported cases of 
collision tumors which have occurred in the uterine corpus.
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CASE REPORT
Oncology & Hematology
INTRODUCTION
A collision tumor is defined by the coexistence of two adjacent, 
but histologically distinct tumor components. This tumor is con-
sidered a multiple synchronous tumor in a single organ, because 
these components are separated from each other by stroma with-
out histologic admixture (1). Collision tumors have been report-
ed in various organs, such as esophagus, stomach, colon, lung, 
skin, thyroid gland, breast, ovary, and uterus (2). Previously re-
ported uterine collision tumors are mainly composed of two 
different histological components; serous or endometrioid ad-
enocarcinoma, and sarcoma or neuroendocrine tumor (2-8). In 
this report, we describe the clinicopathologic features of an un-
usual uterine collision tumor. The tumor is composed of three 
distinct histologic components, endometrioid adenocarcino-
ma, papillary serous carcinoma, and malignant mixed mülleri-
an tumor.
CASE DESCRIPTION
On November 14, 2003, a 70-yr-old female visited our hospital 
due to abnormal uterine bleeding and abdominal pain. Her gy-
necologic history included seven full-term pregnancies, six nor-
mal deliveries, one still birth, and two abortions. Menarche had 
occurred at the age of 17 yr and menstruation was on a regular 
basis. Menopause occurred at the age of 50 yr, and she has never 
received hormone replacement therapy. Past medical history 
includes hypertension, controlled by medication for the past 15 
yr. She has no family history of cancer. Pelvic examination dis-
closed a normal vagina, unremarkable cervix, and an enlarged 
uterus. Transvaginal ultrasonography revealed a 9.2 × 5.9 cm-
sized mass with a mixed echogenic shadow in the uterus, sug-
gesting an endometrial malignancy. Pelvic computed tomogra-
phy displayed a large mass, which occupied the entire endome-
trial cavity with suspicious infiltration to the myometrium and 
parametrial soft tissue. The adjacent organs, such as urinary blad-
der, rectum, and sigmoid colon, were free of tumor extension. 
However, the nodular infiltration of omentum was noted, sug-
gesting the possible omental seeding. Magnetic resonance im-
aging revealed poorly enhancing inhomogeneous mass within 
the uterine cavity with tumor infiltration around the uterus with 
no definitive evidence of lymphadenopathy or extension to the 
adjacent organs. The laboratory test was within normal limit for 
routine blood count, electrolytes, and chemistry. The tumor 
marker, CA125, was elevated to 1,132 U/mL (reference range 0.1-
35 U/mL). On November 17, 2003, exploratory laparotomy was 
performed. There was no evidence of distant metastasis on the 
surface of liver, spleen, diaphragm and peritoneum. However, 
suspicious metastatic nodules were found on omentum and the 
surface of sigmoid colon. The patient underwent total abdomi-
nal hysterectomy with bilateral salphingo-oophorectomy, total 
omentectomy, removal of the mass on the surface of sigmoid Jang K-S, et al.  •  Collision Tumor of the Uterus
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colon, bilateral pelvic and para-aortic lymph node dissection, 
and appendectomy. Intraperitoneal chemotherapy with pacli-
taxel was performed during operation due to the suspicious met-
astatic nodules on omentum and serosa of sigmoid colon. Ad-
juvant chemotherapy (paclitaxel 175 mg/m
2, epirubicin 60 mg/
m
2, and carboplatin AUC 6, every 3 weeks, 6 cycles) and radia-
tion therapy (55 Gy, 6 weeks) were also performed. She had been 
given non-steroidal aromatase inhibitor (Letrozole) orally for 
maintenance therapy, and remained healthy with no evidence 
of recurrence for 8 yr after surgery.
  On gross examination, the uterus was enlarged and measures 
12 × 6.5 × 6 cm in dimensions and 325 gm in weight. The outer 
surface was smooth and glistening without adhesion to adjacent 
soft tissue. On opening of the uterus, there were three separated 
masses arising from the endometrium (Fig. 1). The first was a 
large pedunculated polypoid mass at the anterior wall of the cor-
pus, measuring  8 × 7 × 4.7 cm in dimensions. The surface of the 
first tumor displayed multifocal hemorrhage and necrotic fria-
ble debris, and the cut surface showed solid and fish-flesh ap-
pearance. The second was a broad based and protruding mass 
at the fundus of the corpus, measuring 5 × 4 × 1 cm in dimen-
sions. By sectioning the second tumor, a cut surface of a grayish 
white solid mass was revealed, which invaded one half of the 
myometrium. The third was an irregular elevated mass-like le-
sion, measuring  2.5 × 1.3 × 1 cm in dimensions. The cut surface 
of this lesion showed a grayish white solid mass without defini-
tive myometrial invasion. The histologic findings and immuno-
histochemical staining results of these tumors revealed a malig-
nant mixed müllerian tumor, papillary serous carcinoma, and 
endometrial adenocarcinoma, respectively (Fig. 2). Among these 
components, only the serous carcinoma component revealed 
invasive growth, while the other two components were confined 
to the endometrium. The findings of pathologic examination 
and immunohistochemistry are summarized in Table 1. Pelvic 
and para-aortic lymph nodes showed metastasis of the papillary 
serous carcinoma component. Biopsied tissue from the serosal 
lesion of the sigmoid colon showed seeding of papillary serous 
carcinoma. Both ovaries and salpinx were unremarkable. Col-
lectively, the FIGO stage was IIIc.
DISCUSSION
Tumors with a combination of different histology are divided 
into two clinicopathologic groups, collision or composite tu-
mors (9). The collision tumor has more than two juxtapositioned 
masses and each mass displays a different histology. In a colli-
sion tumor, each mass has a distinct boundary and is separated 
by non-neoplastic stroma. In contrast, the intermingling of more 
than two different components in one tumor mass is designated 
as a composite tumor. The well-known example is a malignant 
mixed müllerian tumor of the uterus. The present case has three 
separate masses located at the fundus, anterior and posterior 
wall of the uterine corpus, with different histology and immun-
ophenotype. Collision tumors of two distinct components have 
already been reported. However, to the best of our knowledge, 
a collision tumor with three distinct components has never been 
reported.
  The clinicopathologic characteristics of the previously reported 
and present uterine collision tumors are summarized in Table 2. 
The mean age of diagnosis was 66.1 yr (range, 47-85 yr). A total 
of 10 patients had 21 separate tumors in the uterine corpus. The 
most frequent histologic type was endometrial adenocarcinoma 
(10/21, 47.6%), followed by homologous and heterologous sar-
comas (4/21, 19.0%), endometrial stromal sarcoma (3/21, 14.2%), 
malignant mixed müllerian tumor (2/21, 9.5%), small cell carci-
noma (1/21, 4.7%), and hepatoid carcinoma (1/21, 4.7%). The 
patients had received total hysterectomy and bilaterial salpingo-
oophorectomy with or without pelvic-paraaortic lymph node 
dissection. Adjuvant chemotherapy and/or radiation therapy 
was performed on three patients (case 6, 7, 10). One patient (case 
4) underwent neoadjuvant chemotherapy before surgical resec-
tion. There is no information on adjuvant treatment on any other 
patients. FIGO stage ranged from Ib to IIIc, and most patients 
had a tumor with an advanced stage. The follow-up informa-
tion was obtained from 7 patients. Four patients died in 4 to 18 
Fig. 1. Macroscopic appearance and schematic view of the hysterectomy specimen. 
(A) The opened uterus reveals a large polypoid mass in the anterior wall and a broad-
based protruding mass in fundus. (B) The posterior wall of uterine corpus shows a 
slightly elevated mass. (C, D) Schematic view of three separate tumors with their patho-
logic diagnosis.
A
C
B
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Table 1. Summary of the pathologic findings and immunohistochemical staining results
Findings Tumor 1 (anterior wall) Tumor 2 (fundus) Tumor 3 (posterior wall)
Gross appearance Large polypoid mass
No myometrial invasion
Broad-based protruding mass
Myometrial invasion
Irregular elevated mass
No myometrial invasion
Histology Malignant mixed müllerian tumor,  
composed of glandular structure  
(carcinomatous) and spindle (sarcomatous)  
cell component
Poorly differentiated serous carcinoma  
with foci of papillary growth
Endometrioid adeonocarcinoma with  
squamous differentiation, architectural  
grade 3 and nuclear grade 3
IHC markers
   ER
   PR
   p53
   Cytokeratin
   Vimentin
   MyoD1
 
Negative
Negative
Positive, 70%
Positive (carcinoma component only)
Positive (sarcoma component only)
Positive, focal
 
Negative
Positive
Positive, 90%
Positive
Negative
Negative
 
Negative
Negative
Positive, 70%
Positive
Negative
Negative
IHC, immunohistochemistry; ER, estrogen receptor; PR, progesterone receptor.
A B
C D
Fig. 2. Histopathology of the hysterectomy specimen HE stained. (A) Papillary serous carcinoma, which is found at fundus of uterine corpus, consists of pleomorphic tumor cells 
with papillary growth pattern. (B) The lymphovascular invasion is present at the periphery of the papillary serous carcinoma. (C) Section from posterior wall consists of endome-
trioid adenocarcinoma, showing glandular and solid growth pattern. (D) Section from polypoid mass reveals malignant mixed müllerian tumor, consisting of carcinomatous and 
sarcomatous components.
months (mean, 8.2 months) after initial diagnosis. The deceased 
patients had tumors with high FIGO stage, two patients with 
FIGO stage IIIb and the others with FIGO stage IIIc. On the other 
hand, two patients who had a relatively lower FIGO stage re-
mained alive up to the last follow-up period. The patient (case 
7) with FIGO stage Ib survived for 6.5 yr and the patient (case 6) 
with FIGO stage IIIa, survived for 1.5 yr. Regardless of histologic 
subtype, the clinical outcome generally depended on tumor 
stage. In contrast to previous cases, the present case presents a 
patient with a collision tumor of FIGO stage IIIc, who remained 
disease-free for 8 yr after the initial diagnosis. The favorable prog-
nosis of this case may be due to the multimodal treatment per-Jang K-S, et al.  •  Collision Tumor of the Uterus
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Table 2. Summary of previously reported collision tumors of the uterine corpus
Case Age Diagnosis Therapy Stage Outcome Ref.
1 55 Adenocarcinoma
Leiomyosarcoma
NA NA NA (5)
2 69 Adenocarcinoma, well differentiated
High-grade stromal sarcoma
TAH with BSO Ib NA (4)
3 67 Endometrioid adenocarcinoma
Homologous sarcoma
TAH IIIb 6 mo, died (7)
4 72 Serous carcinoma
Heterologous sarcoma
TAH, prior CTx IIIc 18 mo, died (7)
5 49 Endometrioid adenocarcinoma
Malignant rhabdoid tumor
TAH with BSO, RTx IIIb 4 mo, died (3)
6 85 Endometrioid adenocarcinoma
Endmetrial stromal sarcoma, high-grade
TAH with BSO IIIa 1.5 yr, alive (2)
7 47 Endometrioid adenocarcinoma
Endmetrial stromal sarcoma, high-grade
TAH with BSO Ib 6.5 yr, alive (2)
8 68 Hepatoid carcinoma
Carcinosarcoma
TAH with BSO IIIa NA (8)
9 79 Papillary serous carcinoma
Small cell carcinoma
TAH with BSO,  
Retroperitoneal LN dissection, RTx
IIIc 5 mo, died (6)
10 70 Papillary serous carcinoma
Endometrioid adenocarcinoma
Malignant mixed müllerian tumor
TAH with BSO, Pelvic-
paraaortic LN dissection,
CTx, RTx
IIIc 8 yr, alive Present case
NA, not available; TAH, total abdominal hysterectomy; BSO, bilateral salpingo-oophorectomy; LN, lymph node; CTx, chemotherapy; RTx, radiation therapy.
formed on the patient. Although advanced metastatic diseases 
generally have a poor survival rate, aggressive surgeries and ad-
juvant therapies may increase such survival rates.
  On reviewing the previously reported cases, pathologic informa-
tion on myoinvasive components was found in 8 cases. Among 
these cases, 4 (case 2, 5, 6, 7) demonstrated invasion of only the 
sarcoma component into the myometrium, whereas the carci-
noma component was confined to the endometrium. These 
cases had endometrioid adenocarcinomas as the carcinoma 
component, known to have a relatively favorable prognosis (10). 
Invasive and metastatic components of collision tumors are 
supposed to be dependent on their original biologic behavior. 
This explanation is supported by cases presenting high-grade 
carcinomas collided with malignant mixed müllerian tumors. 
High-grade carcinomas, such as serous (case 10) and hepatoid 
carcinomas (case 8), display myomterial invasion, whereas ma-
lignant mixed müllerian tumors are confined to the endometri-
um. These pathologic findings suggest that each component of 
collision tumors occur coincidentally with no connection, and the 
biologic behavior depends on their own tumor characteristics.
  The preoperative diagnosis of collision tumor is difficult when 
these tumor components are closely located. In our case, the 
radiologic studies could not discriminate three masses. The pos-
sible explanation includes that one mass was dominantly larger 
than the other two, and all these tumors were arising in the en-
dometrium and faced each other in uterine cavity. Careful patho-
logic examination provides exact tumor stage for each tumor 
and histologic subtype, which can lead to predict correct clini-
cal behavior.
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